Financials

News Ideas Discussions Technicals Forecast Seasonals

3320 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CHINA RESOURCES PHARMACEUTICAL GR operating, investing, and financing activities

3320 free cash flow for H2 24 is 17.61 B HKD. For 2024, 3320 free cash flow was 14.55 B HKD and operating cash flow was 17.55 B HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—